A pilot study to search possible mechanisms of ultralong gonadotropin-releasing hormone agonist therapy in IVF-ET patients with endometriosis

Journal of Ovarian Research

Volumn 7, Issue 1, 2014, Pages

  Tamura, Hiroshi ^a   Takasaki, Akihisa ^b   Nakamura, Yasuhiko ^c   Numa, Fumitaka ^d   Sugino, Norihiro ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Saiseikai Shimonoseki General Hospital   (Japan)

^c Yamaguchi Grand Medical Center   (Japan)

^d Tokuyama Central Hospital   (Japan)

Author keywords

Cytokine; Endometriosis; GnRH agonist; Melatonin; Oxidative stress

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; BUSERELIN ACETATE; CHORIONIC GONADOTROPIN; CONJUGATED ESTROGEN; COPPER ZINC SUPEROXIDE DISMUTASE; DYDROGESTERONE; FOLLITROPIN; HUMAN MENOPAUSAL GONADOTROPIN; INTERLEUKIN 6; MELATONIN; TUMOR NECROSIS FACTOR; 8-OXO-7-HYDRODEOXYGUANOSINE; BIOLOGICAL MARKER; DEOXYGUANOSINE; GONADORELIN; LHRH, ALA(6)-GLY(10)-ETHYLAMIDE-; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; EMBRYO TRANSFER; ENDOMETRIOSIS; FEMALE; HUMAN; IN VITRO FERTILIZATION; INFERTILITY; LUTEAL PHASE; NIDATION; OOCYTE RETRIEVAL; OVARY FOLLICLE FLUID; OVARY FOLLICLE MATURATION; OVARY HYPERSTIMULATION; OVULATION INDUCTION; OXIDATIVE STRESS; PILOT STUDY; PREGNANCY RATE; PRIORITY JOURNAL; ANALOGS AND DERIVATIVES; COMPLICATION; FERTILIZATION IN VITRO; INFERTILITY, FEMALE; METABOLISM; PREGNANCY; PROCEDURES; TREATMENT OUTCOME;

ADULT; BIOMARKERS; DEOXYGUANOSINE; ENDOMETRIOSIS; FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HUMANS; INFERTILITY, FEMALE; MELATONIN; OVULATION INDUCTION; OXIDATIVE STRESS; PILOT PROJECTS; PREGNANCY; PREGNANCY RATE; SUPEROXIDE DISMUTASE; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84965188772     PISSN: None     EISSN: 17572215     Source Type: Journal    
DOI: 10.1186/s13048-014-0100-8     Document Type: Article

References (34)

1. Akande VA, Hunt LP, Cahill DJ, Jenkins JM: Differences in time to natural conception between women with unexplained infertility and infertile women with minor endometriosis. Hum Reprod 2004, 19:96-103.
2. Collins JA, Burrows EA, Wilan AR: The prognosis for live birth among untreated infertile couples. Fertil Steril 1995, 64:22-28.
3. Brizek CL, Schlaff S, Pellegrini VA, Frank JB, Worrilow KC: Increased incidence of aberrant morphological phenotypes in human embryogenesis-an association with endometriosis. J Assist Reprod Genet 1995, 12:106-112.
4. Azem F, Lessing JB, Geva E, Shahar A, Lerner-Geva L, Yovel I, Amit A: Patients with stages III and IV endometriosis have a poorer outcome of in vitro fertilization-embryo transfer than patients with tubal infertility. Fertil Steril 1999, 72:1107-1109.
5. Simon C, Gutierrez A, Vidal A, Santos MJ D l, Tarin JJ, Remohi J, Pellicer A: Outcome of patients with endometriosis in assisted reproduction: results from in-vitro fertilization and oocyte donation. Hum Reprod 1994, 9:725-729.
6. Garrido N, Navarro J, Garcia-Velasco J, Remoh J, Pellice A, Simon C: The endometrium versus embryonic quality in endometriosis-related infertility. Hum Reprod Update 2002, 8:95-103.
7. Augoulea A, Mastorakos G, Lambrinoudaki I, Christodoulakos G, Creatsas G: The role of the oxidative-stress in the endometriosis-related infertility. Gynecol Endocrinol 2009, 25:75-81.
8. Gupta S, Agarwal A, Krajcir N, Alvarez JG: Role of oxidative stress in endometriosis. Reprod Biomed Online 2006, 13:126-134.
9. Jackson LW, Schisterman EF, Dey-Rao R, Browne R, Armstrong D: Oxidative stress and endometriosis. Hum Reprod 2005, 20:2014-2020.
10. Harada T, Yoshioka H, Yoshida S, Iwabe T, Onohara Y, Tanikawa M, Terakawa N: Increased interleukin-6 levels in peritoneal fluid of infertile patients with active endometriosis. Am J Obstet Gynecol 1997, 176:593-597.
11. Falconer H, Sundqvist J, Gemzell-Danielsson K, Von Schoultz B, D'Hooghe TM, Fried G: IVF outcome in women with endometriosis in relation to tumour necrosis factor and anti-Mullerian hormone. Reprod Biomed Online 2009, 18:582-588.
12. Lee KS, Joo BS, Na YJ, Yoon MS, Choi OH, Kim WW: Relationships between concentrations of tumor necrosis factor-alpha and nitric oxide in follicular fluid and oocyte quality. J Assist Reprod Genet 2000, 17:222-228.
13. Iwabe T, Harada T, Tsudo T, Nagano Y, Yoshida S, Tanikawa M, Terakawa N: Tumor necrosis factor-alpha promotes proliferation of endometriotic stromal cells by inducing interleukin-8 gene and protein expression. J Clin Endocrinol Metab 2000, 85:824-829.
14. Yamauchi N, Harada T, Taniguchi F, Yoshida S, Iwabe T, Terakawa N: Tumor necrosis factor-alpha induced the release of interleukin-6 from endometriotic stromal cells by the nuclear factor-kappaB and mitogen-activated protein kinase pathways. Fertil Steril 2004, 82(Suppl 3):1023-1028.
15. Zeller JM, Henig I, Radwanska E, Dmowski WP: Enhancement of human monocyte and peritoneal macrophage chemiluminescence activities in women with endometriosis. Am J Reprod Immunol Microbiol 1987, 13:78-82.
16. Seino T, Saito H, Kaneko T, Takahashi T, Kawachiya S, Kurachi H: Eight-hydroxy-2'-deoxyguanosine in granulosa cells is correlated with the quality of oocytes and embryos in an in vitro fertilization-embryo transfer program. Fertil Steril 2002, 77:1184-1190.
17. Ngo C, Chereau C, Nicco C, Weill B, Chapron C, Batteux F: Reactive oxygen species controls endometriosis progression. Am J Pathol 2009, 175:225-234.
18. Tamura H, Nakamura Y, Korkmaz A, Manchester LC, Tan DX, Sugino N, Reiter RJ: Melatonin and the ovary: physiological and pathophysiological implications. Fertil Steril 2009, 92:328-343.
19. Tamura H, Takasaki A, Taketani T, Tanabe M, Kizuka F, Lee L, Tamura I, Maekawa R, Aasada H, Yamagata Y, Sugino N: The role of melatonin as an antioxidant in the follicle. J Ovarian Res 2012, 5:5.
20. Tamura H, Takasaki A, Taketani T, Tanabe M, Kizuka F, Lee L, Tamura I, Maekawa R, Asada H, Yamagata Y, Sugino N: Melatonin as a free radical scavenger in the ovarian follicle. Endocr J 2013, 60:1-13.
21. Sugino N: The role of oxygen radical-mediated signaling pathways in endometrial function. Placenta 2007, 28(Suppl A):S133-136.
22. Barnhart K, Dunsmoor-Su R, Coutifaris C: Effect of endometriosis on in vitro fertilization. Fertil Steril 2002, 77:1148-1155.
23. Surrey ES, Silverberg KM, Surrey MW, Schoolcraft WB: Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis. Fertil Steril 2002, 78:699-704. 24.
24. Sallam HN, Garcia-Velasco JA, Dias S, Arici A: Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis. Cochrane Database Syst Rev 2006:CD004635
25. Rickes D, Nickel I, Kropf S, Kleinstein J: Increased pregnancy rates after ultralong postoperative therapy with gonadotropin-releasing hormone analogs in patients with endometriosis. Fertil Steril 2002, 78:757-762.
26. Taketani T, Tamura H, Takasaki A, Lee L, Kizuka F, Tamura I, Taniguchi K, Maekawa R, Asada H, Shimamura K, Reiter RJ, Sugino N: Protective role of melatonin in progesterone production by human luteal cells. J Pineal Res 2011, 51:207-213.
27. Tamura H, Nakamura Y, Takiguchi S, Kashida S, Yamagata Y, Sugino N, Kato H: Melatonin directly suppresses steroid production by preovulatory follicles in the cyclic hamster. J Pineal Res 1998, 25:135-141.
28. Tamura H, Nakamura Y, Takiguchi S, Kashida S, Yamagata Y, Sugino N, Kato H: Pinealectomy of melatonin implantation does not affect prolactin surge or luteal function in pseudopregnant rats. Endocr J 1998, 45:377-383.
29. Iwabe T, Harada T, Sakamoto Y, Iba Y, Horie S, Mitsunari M, Terakawa N: Gonadotropin-releasing hormone agonist treatment reduced serum interleukin-6 concentrations in patients with ovarian endometriomas. Fertil Steril 2003, 80:300-304.
30. Kupker W, Schultze-Mosgau A, Diedrich K: Paracrine changes in the peritoneal environment of women with endometriosis. Hum Reprod Update 1998, 4:719-723.
31. Reiter RJ, Tan DX, Fuentes-Broto L: Melatonin: a multitasking molecule. Prog Brain Res 2010, 181:127-151.
32. Tan DX, Manchester LC, Terron MP, Flores LJ, Reiter RJ: One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 2007, 42:28-42.
33. Tamura H, Takasaki A, Miwa I, Taniguchi K, Maekawa R, Asada H, Taketani T, Matsuoka A, Yamagata Y, Shimamura K, Morioka H, Ishikawa H, Reiter RJ, Sugino N: Oxidative stress impairs oocyte quality and melatonin protects oocytes from free radical damage and improves fertilization rate. J Pineal Res 2008, 44:280-287.
34. Cota AM, Oliveira JB, Petersen CG, Mauri AL, Massaro FC, Silva LF, Nicoletti A, Cavagna M, Baruffi RL, Franco JG Jr: GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology. Reprod Biol Endocrinol 2012, 10:33-40.